Surgnova cordially invites you to join our monthly webinar “Step inside IRE Technology-Next Generation of Tumor Ablation” on November 5th, 2021.
To equip people with a broadened outlook of irreversible electroporation (IRE) technology, especially in the field of Hepato-Pancreato-Biliary cancer, Dr. Kai-Wen Huang from National Taiwan University, Dr. Robert C.G. Martin from the University of Louisville in USA, Dr. Luiz Tenório de Brito Siqueira from Rede D’or in Brazil and Dr. Lizhi Niu from Fuda Cancer Hospital, China are going to present their own insightful knowledge and clinical applications in pancreatic cancers and many more. They were all pioneers in their territories to perform the very first IRE procedure in treating pancreatic cancer.
As the next generation of tumor ablation technology, IRE is advancing and empowering cancer treatment. It can ablate tumors in complex physiological parts without harming nearby organs such as blood vessels, nerves, bile ducts, and connective tissues due to its unique working principal. Over the past decade, IRE technology has been mainly applied in treatment of tumors in pancreas, liver, prostate and kidney.